HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines
- 25 February 2009
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 27 (9), 1468-1477
- https://doi.org/10.1016/j.vaccine.2008.11.113
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometryVaccine, 2008
- Selective and Quantitative Detection of Influenza Virus Proteins in Commercial Vaccines Using Two-Dimensional High-Performance Liquid Chromatography and Fluorescence DetectionAnalytical Chemistry, 2007
- Rapid and selective characterization of influenza virus constituents in monovalent and multivalent preparations using non-porous reversed-phase high performance liquid chromatography columnsJournal of Chromatography A, 2006
- Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6® cells: A novel RP-HPLC methodVaccine, 2006
- The annual production cycle for influenza vaccineVaccine, 2003
- Influenza and the work of the World Health OrganizationVaccine, 2002
- Inactivation of DNA by β-propiolactoneBiologicals, 1995
- Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccinesVeterinary Microbiology, 1993
- An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccinesJournal of Biological Standardization, 1977